loading...| Preferred Name |
Severe acute respiratory syndrome |
| ID |
http://www.orpha.net/ORDO/Orphanet_140896 |
| alternative_term |
SARS-1 SARS |
| definition |
A rare pulmonary disease induced by SARS-CoV coronavirus infection, with a reported incubation period varying from 2 to 7 days. Patients present flu-like symptoms, including fever, malaise, myalgia, headache, diarrhoea, and rigors. Dry, nonproductive, cough and dyspnea are frequently reported. Severe cases evolve rapidly, progressing to respiratory distress and failure, requiring intensive care. Mortality rate is 10%. The disease appeared in 2002 in southern China, subsequently spreading in 2003 to 26 countries. Reported human-to-human transmission occurred in Toronto (Canada), Hong Kong Special Administrative Region of China, Chinese Taipei, Singapore, and Hanoi (Viet Nam). |
| definition_citation |
Orphanet |
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=140896 |
| has_age_of_onset |
All ages |
| has_inheritance |
Not applicable |
| hasDbXref |
ICD-10:U04.9 MedDRA:10061982 MeSH:D045169 ICD-11:1D65 UMLS:C1175175 |
| label |
Severe acute respiratory syndrome |
| notation |
ORPHA:140896 |
| part_of | |
| prefixIRI |
ORDO:Orphanet_140896 |
| prefLabel |
Severe acute respiratory syndrome |
| present_in |
Worldwide AND has_point_prevalence_range : Unknown Europe AND has_annual_incidence_range : <1 / 1 000 000 |
| treeView | |
| subClassOf |